investorscraft@gmail.com

Intrinsic Value of F-star Therapeutics, Inc. (FSTX)

Previous Close$0.00
Intrinsic Value
Upside potential
Previous Close
$0.00
* Our model cannot be used “out of the box” for the valuation of this stock. You can still do your own valuation by changing the valuation input parameters.

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2021-12-31 and quarterly data as of 2022-09-30.

  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year(a)2022202320242025202620272028202920302031203220332034203520362037203820392040204120422043204420452046

INCOME STATEMENT

Revenue growth rate, %88.1NaN
Revenue, $21NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m52NaN
Operating income, $m-31NaN
EBITDA, $m-30NaN
Interest expense (income), $mNaN
Earnings before tax, $m-32NaN
Tax expense, $m-0NaN
Net income, $m-31NaN

BALANCE SHEET

Cash and short-term investments, $m79NaN
Total assets, $m123NaN
Adjusted assets (=assets-cash), $m44NaN
Average production assets, $m16NaN
Working capital, $m73NaN
Total debt, $m12NaN
Total liabilities, $m26NaN
Total equity, $m97NaN
Debt-to-equity ratio0.127NaN
Adjusted equity ratio0.412NaN

CASH FLOW

Net income, $m-31NaN
Depreciation, amort., depletion, $m1NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m-27NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m-1NaN
Free cash flow, $m-27NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m73
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount